Notification
No new Notification messages
Hyundai Motor India IPO is Open!
Apply for the Hyundai Motor India IPO through UPI in just minutes
HCL Technologies Q2 Results FY'25
HCL Tech announced its Q2 FY'25 results, revenue jumped by 8.2% YoY at ₹28,862 crores, and Net Income stood at ₹4,235 crores up 10.5% YoY.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
Trade Now, Pay Later with up to 4x Leverage
Never miss a good trading opportunity due to low funds with our MTF feature.
NSE BSE
syncom formu (i) ltd stock

SYNCOM FORMU (I) LTD Share Price

21.03 -0.20 (-0.94%)
Oct 15 2024 03:30 PM Pharmaceuticals NSE: SYNCOMF

SYNCOM FORMU (I) LTD Share Price Update

As of the latest trading session, SYNCOM FORMU (I) LTD share price is currently at 21.03, which is down by -0.20 from its previous closing. Today, the stock has fluctuated between 20.82 and 21.33. Over the past year, SYNCOM FORMU (I) LTD has achieved a return of 137.31 %. In the last month alone, the return has been -14.73 %. Read More...

SYNCOM FORMU (I) LTD Performance

Day Range

Low20.82 High21.33
21.01

52 Week Range

Low 7.25 High 27.90
21.01

SYNCOM FORMU (I) LTD Share Price

11992

524470

SYNCOMF

img img img img
No Data Available

Open Price

21.28

Prev. Close

21.24

Volume (Shares)

2181054.00

Total traded value

458.23

Upper Circuit

23.36

Lower Circuit

19.11

Note: The current prices & values are delayed, Login to your account for live updates.

SYNCOM FORMU (I) LTD Fundamentals


(Standalone)

Market Cap (Cr) 1976.82
PE Ratio (TTM) 73.24
Book Value / Share 3.04
Beta 0.80
ROE 8.71%
EPS (TTM) 0.29
Dividend Yield 0.00%
Net Profit Qtr (Cr) 7.63

SYNCOM FORMU (I) LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 86.83
Operating Expense 78.05
Net Profit 7.63
Net Profit Margin (%) 8.78
Earnings Per Share (EPS) 0.11
EBITDA 11.79
Effective Tax Rate (%) 24.45
Particulars MAR 2024 (Values in Cr)
Revenue 73.27
Operating Expense 66.93
Net Profit 6.75
Net Profit Margin (%) 9.21
Earnings Per Share (EPS) 0.09
EBITDA 11.68
Effective Tax Rate (%) 26.71
Particulars DEC 2023 (Values in Cr)
Revenue 63.34
Operating Expense 59.07
Net Profit 6.42
Net Profit Margin (%) 10.13
Earnings Per Share (EPS) 0.09
EBITDA 11.12
Effective Tax Rate (%) 25.34
Particulars SEP 2023 (Values in Cr)
Revenue 62.39
Operating Expense 58.25
Net Profit 6.21
Net Profit Margin (%) 9.95
Earnings Per Share (EPS) 0.08
EBITDA 10.10
Effective Tax Rate (%) 23.83
Particulars JUN 2023 (Values in Cr)
Revenue 59.36
Operating Expense 55.43
Net Profit 4.25
Net Profit Margin (%) 7.15
Earnings Per Share (EPS) 0.07
EBITDA 8.03
Effective Tax Rate (%) 26.85
Particulars MAR 2024 (Values in Cr)
Revenue 258.36
Operating Expense 239.67
Net Profit 23.62
Net Profit Margin (%) 9.14
Earnings Per Share (EPS) 0.32
EBITDA 40.93
Effective Tax Rate (%) 25.62
Particulars MAR 2023 (Values in Cr)
Revenue 224.64
Operating Expense 212.70
Net Profit 20.07
Net Profit Margin (%) 8.93
Earnings Per Share (EPS) 0.20
EBITDA 34.24
Effective Tax Rate (%) 24.46
Particulars MAR 2022 (Values in Cr)
Revenue 219.66
Operating Expense 205.51
Net Profit 19.79
Net Profit Margin (%) 9.00
Earnings Per Share (EPS) 0.26
EBITDA 32.06
Effective Tax Rate (%) 24.40
Particulars MAR 2021 (Values in Cr)
Revenue 244.81
Operating Expense 211.27
Net Profit 29.17
Net Profit Margin (%) 11.91
Earnings Per Share (EPS) 0.38
EBITDA 45.00
Effective Tax Rate (%) 28.32
Particulars MAR 2020 (Values in Cr)
Revenue 205.51
Operating Expense 193.39
Net Profit 14.25
Net Profit Margin (%) 6.93
Earnings Per Share (EPS) 0.17
EBITDA 21.81
Effective Tax Rate (%) 17.58
Particulars MAR 2024 (Values in Cr)
Book Value / Share 3.07
ROE % 9.30
ROCE % 10.91
Total Debt to Total Equity 0.29
EBITDA Margin 16.48
Particulars MAR 2023 (Values in Cr)
Book Value / Share 2.72
ROE % 8.39
ROCE % 9.57
Total Debt to Total Equity 0.29
EBITDA Margin 15.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 2.52
ROE % 8.91
ROCE % 9.93
Total Debt to Total Equity 0.26
EBITDA Margin 14.59
Particulars MAR 2017 (Values in Cr)
Book Value / Share 1.50
ROE % 9.32
ROCE % 13.22
Total Debt to Total Equity 0.08
EBITDA Margin 10.46
Particulars MAR 2016 (Values in Cr)
Book Value / Share 1.39
ROE % 9.92
ROCE % 14.69
Total Debt to Total Equity 0.06
EBITDA Margin 10.37
Particulars MAR 2024 (Values in Cr)
Book Value / Share 3.05
ROE % 8.71
ROCE % 10.32
Total Debt to Total Equity 0.29
EBITDA Margin 15.94
Particulars MAR 2023 (Values in Cr)
Book Value / Share 2.72
ROE % 8.39
ROCE % 9.57
Total Debt to Total Equity 0.29
EBITDA Margin 15.36
Particulars MAR 2022 (Values in Cr)
Book Value / Share 2.52
ROE % 9.66
ROCE % 10.49
Total Debt to Total Equity 0.29
EBITDA Margin 14.59
Particulars MAR 2021 (Values in Cr)
Book Value / Share 2.25
ROE % 17.51
ROCE % 20.42
Total Debt to Total Equity 0.19
EBITDA Margin 18.47
Particulars MAR 2020 (Values in Cr)
Book Value / Share 1.87
ROE % 10.24
ROCE % 12.18
Total Debt to Total Equity 0.04
EBITDA Margin 10.69
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 67.86
Total Assets 404.66
Total Liabilities 404.66
Total Equity 288.14
Share Outstanding 940000000
Price to Book Ratio 3.67
Return on Assets (%) 6.25
Return on Capital (%) 7.02
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.63
Total Assets 377.83
Total Liabilities 377.83
Total Equity 256.01
Share Outstanding 940000000
Price to Book Ratio 2.17
Return on Assets (%) 5.31
Return on Capital (%) 5.92
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.38
Total Assets 308.23
Total Liabilities 308.23
Total Equity 222.22
Share Outstanding 862453000
Price to Book Ratio 4.22
Return on Assets (%) 6.42
Return on Capital (%) 7.07
Particulars MAR 2017 (Values in Cr)
Cash & Short Term Investments 6.51
Total Assets 180.17
Total Liabilities 180.17
Total Equity 117.35
Share Outstanding 780652180
Price to Book Ratio 1.35
Return on Assets (%) 5.84
Return on Capital (%) 8.12
Particulars MAR 2016 (Values in Cr)
Cash & Short Term Investments 5.69
Total Assets 175.40
Total Liabilities 175.40
Total Equity 108.69
Share Outstanding 780652180
Price to Book Ratio 1.60
Return on Assets (%) 5.90
Return on Capital (%) 9.06
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 67.83
Total Assets 391.50
Total Liabilities 391.50
Total Equity 286.45
Share Outstanding 940000000
Price to Book Ratio 3.67
Return on Assets (%) 6.03
Return on Capital (%) 6.6
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.57
Total Assets 376.94
Total Liabilities 376.94
Total Equity 256.01
Share Outstanding 940000000
Price to Book Ratio 2.17
Return on Assets (%) 5.32
Return on Capital (%) 5.92
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.38
Total Assets 308.23
Total Liabilities 308.23
Total Equity 222.22
Share Outstanding 862453000
Price to Book Ratio 4.22
Return on Assets (%) 6.42
Return on Capital (%) 7.07
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 64.20
Total Assets 291.64
Total Liabilities 291.64
Total Equity 187.58
Share Outstanding 789952180
Price to Book Ratio 1.38
Return on Assets (%) 10.00
Return on Capital (%) 11.68
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 8.57
Total Assets 180.52
Total Liabilities 180.52
Total Equity 145.65
Share Outstanding 780652180
Price to Book Ratio 0.39
Return on Assets (%) 7.89
Return on Capital (%) 9.64
Particulars MAR 2024 (Values in Cr)
Net Income 33.97
Cash from Operations 2.12
Cash from Investing 83.01
Cash from Financing -14.55
Net change in Cash 62.50
Free Cash Flow 10.26
Particulars MAR 2023 (Values in Cr)
Net Income 26.55
Cash from Operations 17.18
Cash from Investing -44.95
Cash from Financing 35.00
Net change in Cash 0.57
Free Cash Flow 37.81
Particulars MAR 2022 (Values in Cr)
Net Income 26.15
Cash from Operations 22.57
Cash from Investing -27.07
Cash from Financing 8.29
Net change in Cash -2.44
Free Cash Flow 33.88
Particulars MAR 2017 (Values in Cr)
Net Income 15.87
Cash from Operations 17.88
Cash from Investing -17.68
Cash from Financing 4.66
Net change in Cash 0.82
Free Cash Flow 30.78
Particulars MAR 2016 (Values in Cr)
Net Income 16.20
Cash from Operations 29.62
Cash from Investing -22.84
Cash from Financing -2.40
Net change in Cash -1.07
Free Cash Flow 32.90
Particulars MAR 2024 (Values in Cr)
Net Income 31.78
Cash from Operations 1.64
Cash from Investing 83.82
Cash from Financing -15.36
Net change in Cash 62.52
Free Cash Flow 9.78
Particulars MAR 2023 (Values in Cr)
Net Income 26.55
Cash from Operations 17.14
Cash from Investing -44.97
Cash from Financing 35.00
Net change in Cash 0.52
Free Cash Flow 37.77
Particulars MAR 2022 (Values in Cr)
Net Income 26.15
Cash from Operations 22.57
Cash from Investing -27.07
Cash from Financing 8.29
Net change in Cash -2.44
Free Cash Flow 33.88
Particulars MAR 2021 (Values in Cr)
Net Income 40.67
Cash from Operations 9.23
Cash from Investing -75.35
Cash from Financing 71.96
Net change in Cash -5.45
Free Cash Flow 11.89
Particulars MAR 2020 (Values in Cr)
Net Income 17.34
Cash from Operations 10.29
Cash from Investing 1.51
Cash from Financing -6.51
Net change in Cash 0.85
Free Cash Flow 12.04
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 61.28 39.79 3.42 469.61 35.27 / 77.70
BLISS GVS PHARMA LTD 127.25 13.11 1.38 1339.97 77.65 / 148.95
CIPLA LTD 1599.80 29.07 4.83 129194.57 1132.00 / 1702.00
FERMENTA BIOTECH LIMITED 313.45 0.00 3.19 922.51 144.45 / 332.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 61.28 92.85 11.65 469.61 35.27 / 77.70
AMRUTAJAN HEALTH LTD 762.80 51.79 7.64 2205.30 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 7671.40 146.40 26.93 19178.50 4050.15 / 8139.85
BLISS GVS PHARMA LTD 127.25 13.73 1.35 1339.97 77.65 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 21.30
  • 26 Days 22.10
  • 10 Days 21.50
  • 50 Days 20.70
  • 12 Days 21.50
  • 100 Days 18.30
  • 20 Days 22.20
  • 200 Days 12.50
21.30
PIVOT
First Resistance 21.73
Second Resistance 22.22
Third Resistance 22.65
First Support 20.81
Second Support 20.38
Third Support 19.89
RSI 44.97
MACD -0.62
Commodity Channel Index (CCI) -61.54
ADX 9.34
Williams % R -41.44

Over 1 Month

down

-14.73

Over 3 Months

down

32.66

Over 6 Months

down

72.68

Over 1 Year

down

137.31

Over 3 Years

down

0.00

Over 5 Years

down

0.00

SYNCOM FORMU (I) LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SYNCOM FORMU (I) LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
49.34
Promoter Holdings
50.56
FII
0.08
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Kedarmal Shankarlal Bankda Shareholding of Promoter and Promoter Group 1.1692612E8 12.44
Vijay Shankarlal Bankda Shareholding of Promoter and Promoter Group 9.8554595E7 10.48
Paradise Vyapar Private Limited Shareholding of Promoter and Promoter Group 4.7186125E7 5.02
Ankit Bankda Shareholding of Promoter and Promoter Group 4.688642E7 4.99
Asha Vijay Bankda Shareholding of Promoter and Promoter Group 4.6054319E7 4.9
Vimla Bankda Shareholding of Promoter and Promoter Group 4.005932E7 4.26
Strand Developers Pvt. Ltd. Shareholding of Promoter and Promoter Group 3.5875E7 3.82
Vijay Bankda Huf Shareholding of Promoter and Promoter Group 1.2068E7 1.28
Payal Ankur Bankda Shareholding of Promoter and Promoter Group 1.172016E7 1.25
Kedarmal Shankarlal Bankda Huf Shareholding of Promoter and Promoter Group 1.048404E7 1.12
Sulabh Rahul Bankda Shareholding of Promoter and Promoter Group 9300100.0 0.99
Rahul Bankda Shareholding of Promoter and Promoter Group 169500.0 0.02
Ankur Vijay Bankda Shareholding of Promoter and Promoter Group 63900.0 0.01

SYNCOM FORMU (I) LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2022-09-09 0.03 Final 2022-09-13 Equity shares 2017-09-21 0.02 Final 2017-09-23 Equity shares 2016-09-22 0.02 Final 2016-09-26 Equity shares 2015-09-16 0.02 Final 2015-09-19 Equity shares 2014-09-18 0.02 Final 2014-09-20 Equity shares 2013-07-10 0.6 Final 2013-07-12 Equity shares 2012-09-20 0.6 Final 2012-09-24 Equity shares 2011-09-22 0.5 Final 2011-09-26 Equity shares 2010-09-23 0.5 Final 2010-09-27 Equity shares 2009-09-24 0.5 Final 2009-09-28 Equity shares 2008-09-23 0.5 Final 2008-09-25 Equity shares 2007-09-20 1.0 Final 2007-09-24 Equity shares 2006-09-19 0.0 Final 2006-09-21 Equity shares 2005-09-22 0.0 Final 2005-09-26 Equity shares
Ex-Date Ex-Bonus Ratio
2013-08-20 2013-08-19 5:2
Ex-Date Old FV NEW FV Record Date
2013-08-19 10.0 1.0 2013-08-20

Learn More About Stocks

About SYNCOM FORMU (I) LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SYNCOM FORMU (I) LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Syncom Formulations (India) Ltd?

Answer Field

The share price of Syncom Formulations (India) Ltd for NSE is ₹ 21.03 and for BSE is ₹ 21.05.

What is the Market Cap of Syncom Formulations (India) Ltd?

Answer Field

The market cap of Syncom Formulations (India) Ltd for NSE is ₹ 19,76.82 Cr. and for BSE is ₹ 19,78.70 Cr. as of now.

What is the 52 Week High and Low of Syncom Formulations (India) Ltd?

Answer Field

The 52 Week High and Low of Syncom Formulations (India) Ltd for NSE is ₹ 27.90 and ₹ 7.25 and for BSE is ₹ 27.94 and ₹ 7.66.

How to Buy Syncom Formulations (India) Ltd share?

Answer Field

You can trade in Syncom Formulations (India) Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Syncom Formulations (India) Ltd?

Answer Field

The 1 year returns on the stock has been 137.31%.

What is the Current Share Price of Syncom Formulations (India) Ltd?

Answer Field

Syncom Formulations (India) Ltd share price is for NSE ₹ 21.03 & for BSE ₹ 21.05 as on Oct 15 2024 03:30 PM.

What is the Market Cap of Syncom Formulations (India) Ltd Share?

Answer Field

The market cap of Syncom Formulations (India) Ltd for NSE ₹ 19,76.82 & for BSE ₹ 19,78.70 as on Oct 15 2024 03:30 PM.

What is the P/E Ratio of Syncom Formulations (India) Ltd Share?

Answer Field

As on Oct 15 2024 03:30 PM the price-to-earnings (PE) ratio for Syncom Formulations (India) Ltd share is 73.24.

What is the PB ratio of Syncom Formulations (India) Ltd Share?

Answer Field

As on Oct 15 2024 03:30 PM, the price-to-book (PB) ratio for Syncom Formulations (India) Ltd share is 3.04.

How to Buy Syncom Formulations (India) Ltd Share?

Answer Field

You can trade in Syncom Formulations (India) Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Syncom Formulations (India) Ltd Share on Bajaj Broking App?

Answer Field

To buy Syncom Formulations (India) Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Syncom Formulations (India) Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader